Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕HDFC MNC Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC MNC Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹666.3420₹14.7710
NAV date20 Nov 202620 Nov 2026
History13.9 years3.7 years
Expense ratio1.0%1.8%
Stars★★★★★★★★★★
Growth Score75.2019.70

Returns

Nippon India Pharma FundHDFC MNC Fund
1 month+11.40%+7.58%
3 months+3.74%−0.75%
6 months+8.55%+8.05%
YTD+16.94%+5.43%
1 year+15.26%+6.62%
3 years (CAGR)+17.96%+7.87%
5 years (CAGR)+15.40%—
10 years (CAGR)+16.61%—
Since launch+17.63%+11.07%

Risk

Nippon India Pharma FundHDFC MNC Fund
Volatility14.1%17.1%
Downside volatility9.0%12.5%
Sharpe0.810.08
Sortino1.280.11
Calmar1.220.32
Return / risk1.270.46
Deepest fall−24.02%−24.53%
Days to recover445—
Below its high+0.00%−5.89%

Against benchmark

Nippon India Pharma FundHDFC MNC Fund
Alpha−1.86%−3.42%
Beta0.890.87
R²89.5%89.3%
Up capture85.2%82.8%
Down capture88.7%94.5%
Tracking error4.8%6.1%
Information ratio−0.69−0.70
Treynor0.120.01

Consistency

Nippon India Pharma FundHDFC MNC Fund
Best 1-year+90.70%+36.06%
Middle 1-year+13.13%+3.96%
Worst 1-year−15.12%−11.20%
1-year periods with a loss23.2%33.8%
Middle 3-year+19.82%+8.05%
Positive months63.9%63.9%
Best day+3.40%+3.18%
Worst day−3.21%−3.84%
Worst 5% day−1.38%−1.50%
Positive days53.7%54.3%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC MNC Fund
5-year XIRR+18.24%—
5-year value₹9,54,076—
3-year XIRR+14.26%+5.49%
1-year XIRR+22.08%+10.78%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth